Showing 1 - 9 of 9
Persistent link: https://www.econbiz.de/10003897672
Persistent link: https://www.econbiz.de/10003449162
Persistent link: https://www.econbiz.de/10003908978
Persistent link: https://www.econbiz.de/10011477734
To what extent is an increased stringency of the Intellectual Property Rights (IPR) system apt to stimulate research cooperation between developed and emerging economies? To address this question, we empirically investigate how international joint research projects in the pharmaceutical sector...
Persistent link: https://www.econbiz.de/10012895510
Persistent link: https://www.econbiz.de/10013179155
Persistent link: https://www.econbiz.de/10011590738
The pharmaceutical industry is a textbook example of a science based sector characterized by high R&D cost, uncertain and spillovers for which patent protection assures appropriability thus providing incentives for innovation. Indeed, Mansfield (1986) found that, absent patent protection, 60...
Persistent link: https://www.econbiz.de/10014216850
This paper investigates patterns of industrial dynamics and competition in the pharmaceutical industry, with particular reference to the consequences of patent expiry in different countries. We focus on the competition at the level of single chemical entities, distinguishing between original...
Persistent link: https://www.econbiz.de/10014048098